期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Quantified Magnetic Resonance Spectroscopy in the Diagnosis of Burning Mouth Syndrome 被引量:1
1
作者 Duzgun Yildirim Deniz Alis +4 位作者 Ceren Alis Filiz Namdar Pekiner Alev Bakir Suha Turkmen Dastan Temirbekov 《Open Journal of Medical Imaging》 2019年第3期33-41,共9页
Purpose: To investigate potential pathological differences in major brain metabolites in burning mouth syndrome (BMS). Materials and Methods: We prospectively evaluated eight patients and six healthy controls with sin... Purpose: To investigate potential pathological differences in major brain metabolites in burning mouth syndrome (BMS). Materials and Methods: We prospectively evaluated eight patients and six healthy controls with single voxel magnetic resonance (MR) spectroscopy throughout 2017 using 3-Tesla MR unit. Metabolite levels measured from the left posterior paracingulate white matter. Raw images were processed with Tarquin version 4.3.10 and area under curve values were automatically calculated for GABA (γ-Aminobutyric acid), Ins (myo-inositole), tNAA (N-Acetylaspartate), tCho (total choline), tCr (total creatine) and GLx (glutamine + Glutamat). Major metabolite levels and all metabolites ratio to tCr calculated and compared between two groups using Mann-Whitney U test. Results: GABA/tCR value of the patients (0.589 ± 0.194, median = 0.515) was significantly higher than control group (0.230 ± 0.067, median = 0.220) (P = 0.002). tNAA/tCR value of the patients (1.106 ± 0.218, median: 1.205), was significantly lower than the control group (1.538 ± 0.401, median: 1.705) (P = 0.028). No significant difference was observed between two groups in terms of all other metabolites (P > 0.05). Conclusion: We demonstrated increased GABA and decreased NAA in the left posterior paracingulate region in BMS patients. We suggest that these metabolite alterations in central nervous system might play a key role in the etiology of the disease by inhibiting the suppression of burning sensation. 展开更多
关键词 BURNING MOUTH SYNDROME BMS GABA MRI SPECTROSCOPY
下载PDF
Cost of Treatment of Chronic Spontaneous Urticaria in Turkey
2
作者 Mehtap Tatar Ayşen Şentürk +10 位作者 Gülpembe Ergin Oğuzhan Esin Tuna Cem Mat Emel Bülbül Başkan Ferda Artüz Mehmet Ali Gürer Nilgün Atakan Serhat İnalöz Selin Sezen Çavuşoğlu Abdülkadir Keskinaslan İsmail Mete Şaylan 《Health》 CAS 2016年第11期1098-1103,共7页
Chronic Spontaneous Urticaria (CSU) is a chronic disease with significant negative impact on quality of life of patients. The direct and indirect costs of the disease can be substantial both for the health care system... Chronic Spontaneous Urticaria (CSU) is a chronic disease with significant negative impact on quality of life of patients. The direct and indirect costs of the disease can be substantial both for the health care system and society. The aim of this research is to estimate the cost of mild, moderate and severe CSU in Turkey and to forecast the cost of the disease from the payer (Social Security Institution—SSI) perspective. Expert opinions with Delphi technique were used in order to determine the cost items and their frequency. A questionnaire was designed to outline resources used in the out-patient, inpatient and emergency care episodes and was answered by dermatologists followed by a consensus meeting. Unit costs were calculated from the price list of the SSI. The annual total cost of treating the disease to the SSI was estimated as 262,111,978TL (94,417,870€) comprising 0.06% of the total healthcare budget in 2013. Since there is limited information about the cost of CSU in Turkey, the methodology and results of this study are unique and very important. 展开更多
关键词 Chronic Idiopathic Urticaria Chronic Spontaneous Urticaria TURKEY COST
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部